NIH-funded research R01 grant

Lower-THC, higher-CBD cannabis to help people cut down on drinking

Official title: Alcohol Use Disorder and Cannabis: Testing Novel Harm Reduction Strategies

Funded at University of Colorado Denver · NIH-11374863 · Data updated 2026-11-12

This project compares switching from high-THC cannabis to low-THC, high-CBD products to see if it helps people with alcohol use disorder reduce or stop drinking.

More Alcohol Use research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startApril 20, 2022
Project endMarch 31, 2027
Funding year2026
Award (this year)$501,086
NIH project number5R01AA029606-05
Project IDNIH-11374863 on NIH RePORTER

Who could benefit from this research

Could help

Adults with alcohol use disorder who currently use high-THC cannabis and want help reducing or stopping alcohol use are the ideal candidates.

Less likely to help

People who do not use cannabis, are not trying to reduce drinking, or have medical reasons to avoid cannabis are unlikely to benefit from this approach.

What this research studies

If you join, you'll be invited because you have alcohol use disorder and currently use high-THC cannabis and want to cut down or quit drinking. You'll be supported to switch to low-THC, higher-CBD cannabis products and followed over time for alcohol use, cravings, anxiety, and biological markers. Your outcomes will be compared to people who continue their usual cannabis use or receive standard care to see which approach leads to better reductions in drinking. The team will use questionnaires, biological samples, and behavioral measures to track changes.

Why it matters

Potential benefit: If successful, this could give people with alcohol problems a safer harm-reduction option and guide clinicians on how to talk about cannabis when helping patients reduce drinking.

How similar studies have gone: Previous evidence is limited and mixed, so this harm-reduction approach is relatively novel with only preliminary support from small studies.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Hutchison, Kent E. — University of Colorado Denver
  • Study coordinator: Hutchison, Kent E.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.